Company Interview / Sideways ASX? Pick your poison says Henry

Key points:

Jennings sees the ASX drifting sideways into August amid bank, housing and resource headwindsUS rates are expected to stay on hold, with inflation still well above targetWiseTech Global (ASX:WTC) faces governance overhang, while Artrya (ASX:AYA) is highlighted as a high-conviction SaaS name

Henry Jennings from Marcus Today outlines a cautious outlook for the ASX as financial year-end tax loss selling, portfolio rebalancing and looming August reporting season create what he describes as a “stock pickers’ market”. Jennings suggests the index is constrained by its heavy weighting to the major banks and big miners, with housing market softness and global rate uncertainty limiting upside. He sees US traders potentially switching off over the northern summer despite strong US GDP, low unemployment and persistent inflation keeping rate cuts off the table.

On sectors and stocks, Jennings views the Australian technology space as under pressure, highlighting WiseTech Global (ASX:WTC) as facing serious sentiment damage amid governance concerns, short interest and regulatory investigations. He floats the possibility that founder Richard White could ultimately consider taking the company private. In contrast, he points to Artrya (ASX:AYA) as a high-growth cardiac-focused SaaS name drawing strong institutional interest and being compared by some managers to Pro Medicus (ASX:PME).

Jennings regards CSL (ASX:CSL) as a “fallen angel” that became too cheap below $100, arguing recent gains reflect investors rediscovering its defensive qualities. He sees further performance hinging on the appointment of a new permanent chief executive.